Table 3.
Variable | Univariable | Multivariable model 1* | Multivariable model 2* | |||
---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age (years) | 1.11 (1.02-1.21) | 0.03 | – | – | – | – |
Age-adjusted CCI score, continuous | 3.30 (1.66-6.55) | 0.001 | 2.94 (1.47-5.89) | 0.002 | 3.06 (1.52-6.15) | 0.002 |
NCCN risk groups | ||||||
High | Reference | |||||
Very high | 1.77 (0.58-5.41) | 0.32 | ||||
BMI at baseline (1 kg/m2 increase) | 0.95 (0.81-1.10) | 0.47 | ||||
BMI change (per 1%/180 days increase) | 0.91 (0.80-1.02) | 0.12 | ||||
SMI at baseline (1 cm2/m2 decrease) | 1.04 (0.96-1.12) | 0.32 | ||||
Sarcopenia at baseline | 1.35 (0.44-4.13) | 0.60 | ||||
SMI change (per 1%/180 days decrease) | 1.09 (1.04-1.15) | 0.001 | 1.09 (1.02-1.16) | 0.007 | – | – |
SMI loss ≥5% (Reference: SMI maintain) | 6.95 (1.54-31.39) | 0.01 | – | – | 5.60 (1.23-25.45) | 0.03 |
SMD at baseline (1 HU decrease) | 1.08 (0.98-1.19) | 0.10 | ||||
SMD change (per 1%/180 days decrease) | 1.05 (0.99-1.11) | 0.09 | ||||
SATI at baseline (1 cm2/m2 increase) | 1.01 (0.97-1.05) | 0.70 | ||||
SATI change (per 1%/180 days increase) | 0.99 (0.96-1.02) | 0.42 | ||||
VATI at baseline (1 cm2/m2 increase) | 1.00 (0.98-1.02) | 0.66 | ||||
VATI change (per 1%/180 days increase) | 0.99 (0.97-1.02) | 0.51 | ||||
TATI at baseline (1 cm2/m2 increase) | 1.00 (0.98-1.01) | 0.85 | ||||
TATI change (per 1%/180 days increase) | 1.01 (0.98-1.04) | 0.48 | 1.03 (0.99-1.07) | 0.10 | – | – |
BMI, body mass index; CI, confidence interval; CCI, Charlson Comorbidity Index; CT, computed tomography; HR, hazard ratio; HU, Hounsfield unit; IQR, interquartile range; NCCN, National Comprehensive Cancer Network; SMD, skeletal muscle radiodensity; SMI, skeletal muscle index; SATI, subcutaneous adipose tissue index; TATI, total adipose tissue index; VATI, visceral adipose tissue index.
Data are mean ± standard error or number (%).
*Multivariable analysis using a backward selection method.